1-[8-(2-Chlorophenyl)-9-(4-chlorophenyl)-9H-purin-6-yl]-4-(ethylamino)-4-piperidinecarboxamide hydrochloride (1:1)(CAS: 686347-12-6)

The compound must comply with GHS classification, REACH regulations, and FDA/EPA related requirements. Regulatory guidelines include safety data sheets (SDS), material safety data sheets (MSDS), and proper labeling to ensure safe handling and storage.

Alternative reagents such as 1-(8-phenyl-9H-purin-6-yl)-4-(ethylamino)-4-piperidinecarboxamide or related analogs can be considered. Isomers and common substitutes include 1-(9H-purin-6-yl)-4-(ethylamino)piperidine-4-carboxamide, providing options for synthetic pathways.

The market trend for this compound reflects growing interest in its potential as a therapeutic agent, particularly in oncology and antimicrobial research. Research is exploring its efficacy and safety, with increasing focus on its application in targeted drug delivery systems.

Waste containing the compound should be collected separately and disposed of through professional waste disposal services. Incineration should be done in an enclosed combustion system to prevent the release of harmful chlorinated compounds. Environmental protection measures include minimizing spillage and ensuring proper containment to avoid soil and water contamination.